Evidence shows Coffee drinkers have a lower risk of liver diseases

Health & LifestyleNews
240

Listen to article (english)

Translate to Spanish or other 102 languages!

Regular coffee drinkers have better liver health, a new review finds. Image for illustration purposes
Regular coffee drinkers have better liver health, a new review finds. Image for illustration purposes

Mega Doctor News

- Advertisement -

MEDICAL NEWS TODAY

An expansive new review published in Biochemical Pharmacology. adds to existing evidence that drinking coffee regularly can help protect and even restore the health of one’s liver by inhibiting scarring and inflammation.

In addition to affirming previously noted associations between coffee and liver health, the review identifies potential molecular pathways that explain these beneficial relationships.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/coffee-lower-risk-liver-diseases?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-09-29&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
STHS Heart is the First RGV Facility to Successfully Implant Innovative, Heart Failure Treatment Device
Next article
Ready-To-Eat Meals Containing Pasta May Be Contaminated with Listeria

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.
- Advertisement -